Effect of insulin-regulated FOXC2 expression in adipocyte differentiation and insulin resistance
Because some receptors exist in the brain, peptide design must consider the blood-brain barrier, which limits access to central targets
EMA safety review of GLP-1 receptor agonists and psychiatric adverse events
[15] As use continues to expand across both diabetes and obesity indications, emergency physicians are increasingly encountering patients on these therapies and their associated complications in the ED
In diagnostic laboratories, plasma/serum Lp(a) concentration is determined mainly by immunochemical methods, i.e., immunoturbidimetric or immunonephelometric, or various immuno-enzyme methods, including ELISA
FAQ: GLP-1 consumer intelligence and social listening What do GLP-1 conversations look like across social platforms